Shenzhen Lifotronic Technology Future Growth
Future criteria checks 5/6
Shenzhen Lifotronic Technology is forecast to grow earnings and revenue by 23.4% and 23% per annum respectively. EPS is expected to grow by 23.5% per annum. Return on equity is forecast to be 23.1% in 3 years.
Key information
23.4%
Earnings growth rate
23.5%
EPS growth rate
Medical Equipment earnings growth | 24.5% |
Revenue growth rate | 23.0% |
Future return on equity | 23.1% |
Analyst coverage | Low |
Last updated | 26 Apr 2024 |
Recent future growth updates
No updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 2,167 | 655 | N/A | 485 | 2 |
12/31/2025 | 1,949 | 566 | 250 | 677 | 4 |
12/31/2024 | 1,455 | 425 | 151 | 369 | 2 |
3/31/2024 | 1,174 | 348 | 268 | 307 | N/A |
12/31/2023 | 1,146 | 329 | 255 | 304 | N/A |
9/30/2023 | 1,119 | 303 | 198 | 287 | N/A |
6/30/2023 | 1,095 | 287 | 113 | 246 | N/A |
3/31/2023 | 1,051 | 272 | 100 | 276 | N/A |
12/31/2022 | 983 | 251 | 88 | 272 | N/A |
9/30/2022 | 907 | 221 | 65 | 209 | N/A |
6/30/2022 | 869 | 207 | 69 | 208 | N/A |
3/31/2022 | 824 | 203 | 57 | 187 | N/A |
12/31/2021 | 778 | 190 | 60 | 182 | N/A |
9/30/2021 | 705 | 173 | 52 | 164 | N/A |
6/30/2021 | 651 | 157 | 68 | 156 | N/A |
3/31/2021 | 596 | 160 | 86 | 142 | N/A |
12/31/2020 | 554 | 144 | 82 | 136 | N/A |
9/30/2020 | 516 | 127 | 60 | 115 | N/A |
6/30/2020 | 477 | 119 | 38 | 104 | N/A |
3/31/2020 | 450 | 111 | 31 | 106 | N/A |
12/31/2019 | 423 | 101 | 24 | 92 | N/A |
9/30/2019 | 400 | 102 | 13 | 83 | N/A |
12/31/2018 | 323 | 81 | 8 | 81 | N/A |
12/31/2017 | 251 | 56 | N/A | 35 | N/A |
12/31/2016 | 175 | 10 | N/A | 28 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 688389's forecast earnings growth (23.4% per year) is above the savings rate (2.9%).
Earnings vs Market: 688389's earnings (23.4% per year) are forecast to grow slower than the CN market (24.2% per year).
High Growth Earnings: 688389's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 688389's revenue (23% per year) is forecast to grow faster than the CN market (14.7% per year).
High Growth Revenue: 688389's revenue (23% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 688389's Return on Equity is forecast to be high in 3 years time (23.1%)